Seven Eight Capital, LP Smith & Nephew PLC Transaction History

Seven Eight Capital, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$21.55 - $27.43 $176,990 - $225,282	8,213 New	8,213 $224,000
Q3 2022 Nov 10, 2022	SELL	$12.1 - $29.35 $7,405 - $17,962	-612 Reduced 6.24%	9,191 $213,000
Q2 2022 Aug 04, 2022	SELL	$27.53 - $33.71 $493,475 - $604,251	-17,925 Reduced 64.65%	9,803 $274,000
Q1 2022 May 11, 2022	BUY	$30.84 - $36.38 $855,131 - $1.01 Million	27,728 New	27,728 $885,000
Q3 2021 Nov 15, 2021	SELL	$34.34 - $44.17 $686,800 - $883,400	-20,000 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$37.86 - $44.01 $757,200 - $880,200	20,000 New	20,000 $869,000

223

30.2M

900

6.6K

Ticker SNN
Exchange OTC
Sector Healthcare
Industry Medical Devices
Shares Outstandng 435,348,000
Market Cap $11.2B
Description
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabi...

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Seven Eight Capital, LP with notifications on news.